Arimidex 1mg FC Tablets
PDF Leaflet Revision Date: 15 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of early and advanced breast cancer in postmenopausal women.
Dosage (summary)
1 mg orally once daily for adults, no dose change for mild/moderate renal or hepatic impairment.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Tamoxifen
- Oestrogen-containing therapies
Contraindications
- Hypersensitivity
- Pre-menopausal women
- Severe renal impairment
- Moderate/severe hepatic disease
Common side effects
- Headache
- Hot flushes
- Nausea
- Rash
- Arthralgia
- Asthenia
Counselling Points
- Take daily at the same time
- Report any unusual bleeding
- Caution when driving if experiencing somnolence
Serious warnings
- May reduce bone mineral density
- Not recommended for pre-menopausal women
Important Disclaimer
The Arimidex 1mg FC Tablets professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
